| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |